(Q45747501)

15 December 2017

title

Potent synergistic effect of sho-saiko-to, a herbal medicine, during vaccine therapy in a murine model of hepatitis B virus carrier (English)

1 reference

15 December 2017

1 reference

0 references

S M Akbar

1

1 reference

15 December 2017

K Yamamoto

2

1 reference

15 December 2017

M Abe

3

1 reference

15 December 2017

T Ninomiya

4

1 reference

15 December 2017

K Tanimoto

5

1 reference

15 December 2017

T Masumoto

6

1 reference

15 December 2017

K Michitaka

7

1 reference

15 December 2017

N Horiike

8

1 reference

15 December 2017

M Onji

9

1 reference

15 December 2017

publication date

1 September 1999

1 reference

15 December 2017

European Journal of Clinical Investigation

published in

1 reference

15 December 2017

volume

29

1 reference

15 December 2017

issue

9

1 reference

15 December 2017

page(s)

786-792

1 reference

15 December 2017

Interferon in the management of chronic hepatitis B.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00533.X

Effect of sho-saiko-to(xiao-chai-hu-tang) on HBeAg clearance in children with chronic hepatitis B virus infection and with sustained liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00533.X

Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00533.X

Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00533.X

Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00533.X

Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00533.X

Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00533.X

Expression and replication of hepatitis B virus genome in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00533.X

Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-gamma: abrogation of immune response defect to a T-cell-dependent antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00533.X

Sho-saiko-to, a traditional Kampo medicine, enhances the anti-HIV-1 activity of lamivudine (3TC) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00533.X

Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00533.X

10.1046/J.1365-2362.1999.00533.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017